序贯高强度聚焦超声(HIFU)消融治疗良性多结节性甲状腺肿:一项观察性回顾性研究
该观察性回顾性研究比较了序贯HIFU消融两个优势结节与单次HIFU消融单个结节的疗效与安全性。104例(84.6%)患者接受单次消融单个结节(I组),19例(15.4%)接受序贯消融两个相对优势结节(II组)。两组结节3个月和6个月体积缩小率(VRR)相当(p>0.05),II组第一与第二结节间3个月和6个月VRR也相当(p=0.710和p=0.548)。II组消融后次日晨疼痛评分显著更高(2.29 vs 1.15,p=0.047),恶心/呕吐发生率显著更高(15.8% vs 0.0%,p=0.012),但声带麻痹和皮肤灼伤率相当(p>0.05)。结论认为序贯消融疗效与安全性与单次消融相当,但序贯消融患者次日晨疼痛和消融后恶心/呕吐可能性更高。
要点
- 序贯HIFU消融两个优势结节与单次消融单个结节的3个月和6个月体积缩小率相当(p>0.05)。
- II组消融后次日晨疼痛评分显著高于I组(2.29 vs 1.15,p=0.047)。
- II组恶心/呕吐发生率显著高于I组(15.8% vs 0.0%,p=0.012),声带麻痹和皮肤灼伤率两组相当(p>0.05)。
核心结论
- 序贯消融的疗效和安全性(以体积缩小率、声带麻痹、皮肤灼伤评价)与单次消融相当;但序贯消融患者消融后次日晨疼痛和恶心/呕吐的可能性更高。
诊断标准与关键数值
- 结节缩小程度以体积缩小率(VRR)评价,两组结节3个月和6个月VRR相当(p>0.05)。
- II组第一与第二结节间3个月VRR和6个月VRR相当(p=0.710和p=0.548)。
- 疼痛评分采用0-10视觉模拟量表,II组消融后次日晨评分2.29 vs I组1.15(p=0.047)。
- 恶心/呕吐发生率II组15.8% vs I组0.0%(p=0.012)。
- 声带麻痹和皮肤灼伤发生率两组相当(p>0.05)。
临床应用与阅片要点
- 对于有两个优势结节的多结节性甲状腺肿患者,序贯HIFU消融的疗效与单次消融单个结节相当,且19例(100%)序贯消融均成功完成。
- 序贯消融后患者次日晨疼痛评分更高(2.29 vs 1.15,p=0.047),恶心/呕吐更常见(15.8% vs 0.0%,p=0.012),阅片和报告时应关注这些不良反应。
- 声带麻痹和皮肤灼伤在序贯消融与单次消融间无显著差异(p>0.05),但仍需常规评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Assessing the efficacy and safety of sequential high-intensity focused ultrasound (HIFU) ablation in a multinodular goitre (MNG) by comparing them with single HIFU ablation.
METHODS: One hundred and four (84.6%) patients underwent single ablation of a single nodule (group I), while 19 (15.4%) underwent sequential ablation of two relatively-dominant nodules in a MNG (group II). Extent of shrinkage per nodule [by volume reduction ratio (VRR)], pain scores (by 0-10 visual analogue scale) during and after ablation, and rate of vocal cord palsy (VCP), skin burn and nausea/vomiting were compared between the two groups.
RESULTS: All 19 (100%) sequential ablations completed successfully. The 3- and 6-month VRR of each nodule were comparable between the two groups (p > 0.05) and in group II, the 3- and 6-month VRR between the first and second nodules were comparable (p = 0.710 and p = 0.548, respectively). Pain score was significantly higher in group II in the morning after ablation (2.29 vs 1.15, p = 0.047) and nausea/vomiting occurred significantly more frequently in group II (15.8% vs 0.0%, p = 0.012). However, VCP and skin burn were comparable (p > 0.05).
CONCLUSIONS: Sequential ablation had comparable efficacy and safety as single ablation. However, patients undergoing sequential ablation are at higher likelihood of pain in the following morning and nausea/vomiting after ablation.
KEY POINTS: • Sequential HIFU ablation is well-tolerated in patients with two dominant thyroid nodules • More pain is experienced in the morning following sequential HIFU ablation • More nausea/vomiting is experienced following sequential HIFU ablation.
引用
- Lang BHH, Woo YC, Chiu KW, et al. Sequential high intensity focused ultrasound (HIFU) ablation in the treatment of benign multinodular goitre: an observational retrospective study. Eur Radiol. 2018. PMID: 29556769. doi:10.1007/s00330-018-5333-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。